Brief: Orexo: Gesynta Pharma Announces Positive Results From Phase 1 Study For OX-MPI

Orexo AB

15/05/2020 09:57

May 15 (Reuters) - Orexo AB  ORX.ST :
    * OREXO'S PARTNER GESYNTA PHARMA ANNOUNCES POSITIVE RESULTS
FROM
PHASE 1 STUDY FOR OX-MPI
    * OREXO'S PARTNER, GESYNTA PHARMA, TODAY ANNOUNCES POSITIVE
PHASE
I RESULTS FOR OX-MPI (GS-248)

Source text for Eikon:  ID:nWkr4S5Bzq 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))